# Doxapram as an Additive to Propofol Sedation in Sedation for ERCP

> **NCT02171910** · PHASE4 · COMPLETED · sponsor: **Helsinki University Central Hospital** · enrollment: 50 (actual)

## Conditions studied

- Sedation
- Hypoxia

## Interventions

- **DRUG:** Doxapram
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02171910
- **Lead sponsor:** Helsinki University Central Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2016-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02171910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02171910, "Doxapram as an Additive to Propofol Sedation in Sedation for ERCP". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02171910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*